P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL

ABSTRACT:

SUBMITTER: Strati P 

PROVIDER: S-EPMC9429229 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature